Genzyme (GENZ) Sinks After Interrupting Production at Allston Plant

Shares of Genzyme Corp. (Nasdaq: GENZ) are under heavy pressure this AM after the company announced it will temporarily interrupt bulk production at its Allston Landing manufacturing facility after it has detected a virus that impairs cell growth in one of six bioreactors.

The company expects the plant to be fully operational by the end of July.

Shares of Genzyme are down 6.8% currently.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Goldman says buy this EU power stock
• Mizuho sees a chance to buy this biotech stock after recent weakness
• This EU name is becoming "a structural beneficiary of AI power infrastructure"